Table 2. ICSBP -Transcript Numbers From... | American Society of Hematology

Table 2.

ICSBP-Transcript Numbers From CML Patients Treated With IFN-α During Follow-up

Patient No.	ICSBP-Transcript Levels
Patient No.	At Diagnosis	Early IFN-α Treatment	Late IFN-α Treatment*
1	−	+	−
2	−	+	−/+
3	−	+	ND
4	−	−/+	−/+
5	−	+	−
6	−	−	−
7	−	+	ND
8	−	+	−/+
9	−	+	−/+
10	−	+	−
11	−	−/+	ND
12	−	+	−

Patient No.	ICSBP-Transcript Levels
Patient No.	At Diagnosis	Early IFN-α Treatment	Late IFN-α Treatment*
1	−	+	−
2	−	+	−/+
3	−	+	ND
4	−	−/+	−/+
5	−	+	−
6	−	−	−
7	−	+	ND
8	−	+	−/+
9	−	+	−/+
10	−	+	−
11	−	−/+	ND
12	−	+	−

Abbreviations: ND, not determined; −, no/low ICSBPexpression; −/+, moderate ICSBP expression; +, highICSBP expression.

Progression of CML.